D'ERASMO, Emilio
 Distribuzione geografica
Continente #
NA - Nord America 3.446
EU - Europa 659
AS - Asia 344
SA - Sud America 29
AF - Africa 9
OC - Oceania 2
Totale 4.489
Nazione #
US - Stati Uniti d'America 3.420
IT - Italia 172
IN - India 165
UA - Ucraina 148
CN - Cina 124
SE - Svezia 111
FI - Finlandia 93
SG - Singapore 44
DE - Germania 31
GB - Regno Unito 29
IE - Irlanda 29
AR - Argentina 27
CA - Canada 25
BG - Bulgaria 16
BE - Belgio 14
NL - Olanda 7
TG - Togo 5
CH - Svizzera 4
TH - Thailandia 3
TR - Turchia 3
AU - Australia 2
PH - Filippine 2
RO - Romania 2
SC - Seychelles 2
ZA - Sudafrica 2
BR - Brasile 1
CL - Cile 1
ES - Italia 1
FR - Francia 1
IR - Iran 1
KR - Corea 1
MX - Messico 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 4.489
Città #
Fairfield 557
Woodbridge 295
Ashburn 257
Ann Arbor 243
Chandler 242
Seattle 216
Houston 193
Cambridge 173
Wilmington 169
Princeton 117
San Paolo di Civitate 110
Plano 89
Dearborn 82
Lawrence 76
Jacksonville 58
Boston 52
Beijing 42
Millbury 42
San Diego 41
Fremont 36
Rome 32
Des Moines 30
Dublin 29
Federal 27
Andover 25
Boardman 22
Singapore 18
Norwalk 17
Sofia 16
Hefei 15
Toronto 14
New York 13
Bühl 11
Brussels 10
Nanjing 9
Ottawa 9
Priverno 9
Jinan 8
Falls Church 7
Kunming 7
Auburn Hills 6
Helsinki 6
Los Angeles 6
Nanchang 6
Bremen 5
Lomé 5
Redmond 5
Tappahannock 5
Guangzhou 4
London 4
Mykolayiv 4
Naples 4
Salerno 4
Waanrode 4
Buffalo 3
Chengdu 3
Istanbul 3
Pittsburgh 3
Zurich 3
Chieti 2
General Trias 2
Hangzhou 2
Indiana 2
Kilburn 2
Mahé 2
Ningbo 2
Provo 2
Shenyang 2
Southend 2
Taiyuan 2
Wuhan 2
Amsterdam 1
Ashland 1
Baotou 1
Bern 1
Changsha 1
Chapel Hill 1
Ciampino 1
Council Bluffs 1
Edinburgh 1
Fuzhou 1
Hanam 1
Hobart 1
Hounslow 1
Jiaxing 1
Las Vegas 1
Laurel 1
Leawood 1
Markham 1
Milan 1
Muizenberg 1
Nanning 1
Nuremberg 1
Olinda 1
Palermo 1
Paris 1
Philadelphia 1
Portland 1
Prescot 1
Pune 1
Totale 3.554
Nome #
Bone mineral metabolism in patients with neurofibromatosis type 1 (von Recklingausen disease) 97
The Effect of Recombinant PTH(1-34) and PTH(1-84) on Serum Ionized Calcium, 1,25-Dihydroxyvitamin D, and Urinary Calcium Excretion: A Pilot Study 87
Calcium homeostasis during oral glucose load in healthy women 83
Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism 82
An unusual association of cerebral meningioma, parathyroid adenoma and thyroid papillary carcinoma 80
Acute hyperinsulinemia is associated with increased plasma adrenomedullin concentrations in uncomplicated obesity 79
Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease 78
Adrenomedullin concentrations are elevated in plasma of patients with primary hyperparathyroidism 76
Quality of life in ambulatory postmenopausal women: the impact of reduced bone mineral density and subclinical vertebral fractures 76
Multiple catecholamine-secreting paragangliomas: Diagnosis after hemorrhagic stroke in a young woman 75
A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours 74
Annual skeletal balance and metabolic bone marker changes in healthy early postmenopausal women: Results of a prospective study 71
HYPOCALCEMIA AND HYPOMAGNESEMIA IN CANCER-PATIENTS 71
Skeletal involvement in patients with diabetes mellitus 70
Morphometric X-ray absorptiometry in the assessment of vertebral fractures in renal transplant patients 70
Significance of early increase in stable and radioactive plasma calcium after parathyroidectomy in primary hyperparathyroidism 69
Plasma levels of adrenomedullin in patients with adrenoleukodystrophy/adrenomyeloneuropathy 68
High plasma levels of human chromogranin A and adrenomedullin in patients with pheochromocytoma 66
Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage? 66
ACCURACY OF VERTEBRAL FRACTURE ASSESSMENT BY DUAL-ENERGY X-RAY ABSORPTIOMETRY USING GE IDXA COMPARED TO CONVENTIONAL RADIOGRAPHY 64
Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol 64
Biomarkers of bone turnover after a short period of steroid therapy in elderly men 63
Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly 63
A HOSPITAL SURVEY OF HYPOCALCEMIA AND HYPOPHOSPHATEMIA IN MALIGNANCY 63
False-positive diagnosis of adrenal pheochromocytoma on iodine-123-MIBG scan 62
Acute effects of removal of parathyroid adenoma on plasma and urinary hydroxyproline levels 62
Impact of fractures on health care in a major university hospital in Rome 62
Cyclical changes of vertebral body heights and bone loss in healthy women after menopause 61
Absence of somatic mutations in natriuretic peptide receptor type A gene in human aldosterone-secreting adenomas 61
Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis 61
Cyclical behavior of bone remodeling and bone loss in healthy women after menopause: Results of a prospective study 60
Adrenomedullin, a new peptide, in patients with insulinoma 59
Plasma adrenomedullin concentrations in patients with adrenal pheochromocytoma 59
Calcitonin secretion and bone disease severity in hypercalcaemic hyperparathyroidism 59
Serum albumin level at admission: mortality and clinical outcome in geriatric patients. 58
[Primary hyperparathyroidism]. 58
The risk of fractures in postmenopausal women with primary hyperparathyroidism 57
Incidence of normocalcemic hyperparathyroidism in idiopathic hypercalciuria: Evaluation by dietary calcium deprivation test 57
Serum osteocalcin and bone mineral density at various skeletal sites: A study performed with three different assays 57
COEXISTENT MULTIPLE-MYELOMA AND MEN TYPE-1 57
Dehydroepiandrosterone sulfate and bone resorption rates as reflected by serum levels of C-terminal telopeptide of type I collagen: A study in healthy men 56
High prevalence of epilepsy in a village in the Littoral Province of Cameroon 56
Relationship between spine bone mineral density and vertebral body heights 56
Changes in adrenomedullin plasma concentrations during haemodialysis in patients with chronic renal failure 55
Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects 53
P53 as a marker of differentiation between hyperplastic and adenomatous parathyroids 52
Plasma calcitonin and tumors. 52
Type II benign osteopetrosis (Albers-Schonberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations 52
Pulmonary lymphangioleiomyoma in a patient with multiple endocrine neoplasia Type I 52
Relationship between serum albumin and bone mineral density in postmenopausal women and in patients with hypoalbuminemia 51
Pathogenethic aspects of involutional osteoporosis 50
CONCURRENT IMPROVEMENT OF NEUROMUSCULAR AND SKELETAL INVOLVEMENT FOLLOWING SURGERY FOR PRIMARY HYPERPARATHYROIDISM 49
Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone 45
Adrenomedullin. A new peptide involved in the regulation of the cardiovascular system 44
Expression of potassium channel isoforms mRNA in normal human adrenals and aldosterone-secreting adenomas 44
Correlation between bone mineral density (BMD) of lumbar spine and vertebral morphometry. 43
Total thyroidectomy and synchronous video assisted lung metastasectomy in differentiated thyroid carcinoma 43
The functional HERG variant 897T is associated with Conn's adenoma 42
[Clinical and prognostic importance of changes in the number of circulating lymphocytes in cerebral infarction of the ischemic type]. 42
Metabolic bone diseases during long-term total parenteral nutrition. 41
Circulanting leptin and adinopectin levels in patients with primary hiperparathyroidism 41
RECURRENT HYPERPARATHYROIDISM - A STUDY OF 3 CASES WITH EVALUATION OF SOME PATHOGENETIC AND CLINICAL ASPECTS 40
Biochemical markers in glucocorticoid-induced osteoporosis. 38
Circulating adrenomedullin is increased in patients with corticotropin-dependent Cushing's syndrome due to pituitary adenoma 36
Ionised and total serum magnesium in renal transplant patients 36
Chronic constipation in hypercalcemic patients with primary hyperparathyroidism 36
[Effects of the combined raloxifene-sodium fluoride therapy on bone mass and bone turnover in women with postmenopausal osteoporosis]. 36
[Effects of thiazide diuretics on the regulation mechanisms of calcium and phosphorus metabolism]. 35
PHYSIOLOGICAL-CHANGES IN VERTEBRAL MORPHOMETRY WITH AGING 35
Plasma Adrenomedullin Concentrationís in Patients with Adrenal Pheochromocytoma 35
Calcolosi Renale 33
[Incidentalomas of the adrenal glands. Personal cases and review of the literature]. 32
Hyponatremia in clinical practice 31
The use of parenteral clodronate in elderly women with postmenopausal osteoporosis: compliance, effects on bone mineral density and on bone turnover 31
High prevalence of thyroid disfunction in primary hyperaldosteronism 30
BONE MASS, BONE METABOLISM, AND PREVALENCE OF SPINAL FRACTURES IN RECIPIENTS OF ALLOGENIC BONE MARROW TRANSPLANTATION FOR LEUKEMIA 30
BONE MASS AS REFERENT FOR URINARY HYDROXYPROLINE EXCRETION 30
Effects of alcohol abuse on bone turnover and fracture prevalence in male patients 27
Variazioni diurne/notturne della pressione arteriosa e della frequenza cardiaca nella sindrome metabolica 27
Sporadic and hereditary primary hyperparathyroidism. 27
[Non-hormonal therapy of diabetes insipidus]. 25
Vertebral morphometry and thoracic kyphosis 24
[Studies of the half-life of plasma parathyroid hormone: rate of disappearance of immunoreactive fragments of the hormone after surgical removal of the parathyroid adenoma in primary hyperparathyroidism]. 24
[Plasma osteocalcin in children: effects of age, sex and body surface]. 24
Hyperhomocysteinemia: a biochemical link between bone and cardiovascular system diseases? 22
INCREASED PLASMA ADRENOMEDULLIN CONCENTRATIONS IN PATIENTS WITH RAYNAUD PHENOMENON 20
Vertebral morphometry and risk of vertebral fractures 18
Cardiovascular disease and osteoporosis. 16
Renin-angiotensin-aldosterone and endothelin-1 systems in primary hyperparathyroidism associated with arterial hypertension 16
Phalangeal quantitative ultrasound and bone mineral density in evaluating cortical bone loss. a study in postmenopausal women with hyperparathyroidism and subclinical iatrogenic hyperthyroidism 11
Totale 4.549
Categoria #
all - tutte 11.162
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.162


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019413 0 0 0 0 0 0 0 0 0 0 235 178
2019/20201.210 166 40 9 57 110 200 188 158 129 87 43 23
2020/2021326 50 42 17 22 6 51 16 30 29 41 19 3
2021/2022913 3 75 84 28 106 13 20 109 73 76 145 181
2022/2023926 199 244 38 109 77 91 7 35 95 4 17 10
2023/2024232 22 59 6 18 18 35 2 9 1 44 18 0
Totale 4.549